BEAM Beam Therapeutics
- 23.840
- -0.010-0.04%
- 23.840
- 0.0000.00%
Beam Therapeutics News
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Simon Amy
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Evans John M.
Beam Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Beam Therapeutics | 8-K: Current report
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shaw Christi
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MARAGANORE JOHN
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Carole
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director COOPER GRAHAM K
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Walsh Kathleen E
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fishman Mark
Beam Therapeutics | 10-Q: Quarterly report
Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
Beam Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burrell Terry-Ann
Beam Therapeutics | ARS: Annual Report to Security Holders
Beam Therapeutics | DEFA14A: Others
Beam Therapeutics | DEF 14A: Definitive information statements
Beam Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Beam Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Beam Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Beam Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
